Epidermolysis bullosa acquisita

Get in touch with RARE Concierge.

Contact RARE Concierge

Epidermolysis bullosa acquisita

Synonyms: Acquired epidermolysis bullosa

A rare chronic incurable sub epithelial autoimmune bullous disease characterized by the presence of tissue bound autoantibodies against type VII collagen within the basement membrane zone of the dermal-epidermal junction of stratified squamous epithelia. The patient’s serum may also have anti-type VII collagen autoantibodies. The clinical presentation is varied and may involve the skin oral mucosa and the upper third of the esophagus. The classical presentation is reminiscent of hereditary dystrophic epidermolysis bullosa (EB) with skin fragility blisters and erosions and skin scarring. Other non-classical clinical presentations include an inflammatory bullous pemphigoid-like eruption a mucous membrane pemphigoid-like eruption and an IgA bullous dermatosis-like disease.

Data from Orphanet are used to provide information on a disease's name, synonym(s), and overview.

Reference: Access aggregated data from Orphanet at Orphadata.

Orphadata: Free access data from Orphanet. © INSERM 1999. Available on http: //www.orphadata.org. Data version September 2023.

Newly diagnosed with
Epidermolysis bullosa acquisita?

Our RARE Concierge Services Guides are available to assist you by providing information, resources and connections as you navigate your rare disease journey.

Get Concierge Help

Advocacy Organizations

the fairy goddess mother project inc

The Fairy Goddess Mother Project is dedicated to increasing awareness of Vulvar Lichen Sclerosus (VLS), providing financial assistance to women needing treatment, and supporting patient’s efforts to participate in clinical trials.

the fairy goddess mother project inc

The Fairy Goddess Mother Project is dedicated to increasing awareness of Vulvar Lichen Sclerosus (VLS), providing financial assistance to women needing treatment, and supporting patient’s efforts to participate in clinical trials.

Clinical Trials

For a list of clinical trials in this disease area, please click here.